Log in to your Inderes Free account to see all free content on this page.
BioInvent International
23.40 SEK
+5.17 %
Less than 1K followers
BINV
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for BioInvent International
EV/S
Median 2019-2024
P/B
Median 2019-2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Share price (SEK) | 30.01 | 45.90 | 46.20 | 32.05 | 18.96 | 38.50 | 29.40 |
| Shares | 20.4 | 39.4 | 58.5 | 65.0 | 65.8 | 65.8 | 65.8 |
| Market cap | 613.2 | 1,807.4 | 2,701.4 | 2,082.2 | 1,247.6 | 2,533.5 | 1,934.6 |
| Enterprise value | 474.7 | 1,089.7 | 1,819.0 | 1,594.1 | 1,011.3 | 2,116.0 | - |
| EV/S | 5.1 | 7.4 | 93.8 | 4.9 | 14.2 | 47.3 | - |
| EV/EBITDA | neg. | neg. | neg. | neg. | neg. | neg. | - |
| EV/EBIT | neg. | neg. | neg. | neg. | neg. | neg. | - |
| P/E | neg. | neg. | neg. | neg. | neg. | neg. | neg. |
| P/B | 3.62 | 2.43 | 1.98 | 1.30 | 0.95 | 2.86 | 3.47 |
| P/S | 6.5 | 12.3 | 139.4 | 6.4 | 17.5 | 56.7 | 8.5 |
| Dividend yield | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
| Equity ratio | 74.9 % | 92.6 % | 94.5 % | 93.8 % | 93.5 % | 89.5 % | 83.1 % |
| Gearing ratio | 9.2 % | 1.6 % | 2.1 % | 1.7 % | 1.8 % | 2.0 % | 1.5 % |
Login required
This content is only available for logged in users